B38 Coccidioidomycosis

Name of the Condition

• Coccidioidomycosis

Summary

Coccidioidomycosis, also known as Valley fever, is a fungal infection caused by Coccidioides species. It primarily affects the lungs but can disseminate to other organs. The condition ranges from asymptomatic or mild respiratory illness to severe, progressive disease, particularly in immunocompromised individuals.

Causes

The infection is caused by inhaling airborne spores of Coccidioides fungi, which are endemic to arid regions like the southwestern United States, Mexico, and parts of Central and South America. The fungi thrive in soil and are released into the air during activities that disturb the ground, such as construction or farming.

Risk Factors

• Residence or travel to endemic regions, especially during dry, dusty seasons.
• Occupational exposure to soil (e.g., farmers, construction workers, archaeologists).
• Immunocompromised states, including HIV/AIDS, organ transplantation, or prolonged corticosteroid use.
• Pregnancy, particularly the third trimester.
• Advanced age.

Symptoms

• Fatigue and malaise.
• Cough, chest pain, or shortness of breath.
• Fever, night sweats, or weight loss.
• Joint pain or skin rash (erythema nodosum).
• Severe cases may involve meningitis, bone lesions, or disseminated infection.

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., chest X-ray or CT), and laboratory tests. Common methods include serologic testing for Coccidioides antibodies, fungal cultures, or antigen detection. Histopathology of tissue samples may confirm disseminated disease.

Treatment Options

• Mild cases often resolve without specific therapy.
• Antifungal medications (e.g., fluconazole, itraconazole) are used for moderate to severe or disseminated disease.
• Treatment duration varies, typically lasting months to years for chronic or disseminated infections.
• Supportive care, such as rest and hydration, may alleviate symptoms.

Prognosis and Follow-Up

Most healthy individuals recover fully, but fatigue may persist. Immunocompromised patients or those with disseminated disease require long-term monitoring and treatment. Follow-up includes clinical assessments and imaging to detect recurrence or complications.

Complications

• Chronic pulmonary coccidioidomycosis (persistent lung infection).
• Disseminated disease affecting the meninges, bones, or skin.
• Respiratory failure in severe cases.
• Increased risk of mortality in immunocompromised hosts.

Lifestyle & Prevention

• Avoid dusty areas in endemic regions, especially during dust storms.
• Use masks or respirators in high-risk environments.
• Stay indoors during peak dust activity.
• Maintain overall health to support immune function.

When to Seek Professional Help

Seek care if symptoms persist beyond a few weeks, worsen, or include severe respiratory distress, persistent fever, or neurological signs (e.g., headache, confusion). Immunocompromised individuals should consult promptly with new respiratory symptoms in endemic areas.

Tips for Medical Coders

Document the clinical presentation (e.g., pulmonary, disseminated) and any underlying immunocompromising conditions. Specify if the infection is acute or chronic, as this may impact coding. Ensure alignment with ICD-10-CM guidelines for Coccidioides infections (B38) and related manifestations.